Adarza BioSystems Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Out of Business

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Out of Business

Adarza BioSystems General Information

Description

Developer of a biological assay platform designed to measure clinical and point-of-care samples. The company's platform offers label-free diagnostic arrayed imaging reflectometry (AIR) that is capable of simultaneous detection of hundreds of analytes in a single drop of fluid, enabling healthcare professionals to detect highly multiplexed protein with high sensitivity and specificity.

Contact Information

Website
www.adarzabio.com
Formerly Known As
Pathologics Associates
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 2184 Welsch Industrial Court
  • Saint Louis, MO 63146
  • United States
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Diagnostic Equipment
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • 2184 Welsch Industrial Court
  • Saint Louis, MO 63146
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adarza BioSystems Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 01-May-2022 Completed Out of Business
10. Debt - PPP 12-Apr-2020 Completed Generating Revenue
9. Later Stage VC (Series D) 04-Feb-2020 Completed Generating Revenue
8. Later Stage VC (Series C) 21-Dec-2017 Completed Generating Revenue
7. Later Stage VC (Series B) 24-Mar-2016 Completed Generating Revenue
6. Grant 21-Mar-2016 Completed Generating Revenue
5. Later Stage VC (Series A) 04-Jun-2014 Completed Generating Revenue
4. Grant 14-May-2013 Completed Startup
3. Grant 01-Jan-2012 $27.5K $100K Completed Startup
2. Early Stage VC $100K $100K Completed Startup
To view Adarza BioSystems’s complete valuation and funding history, request access »

Adarza BioSystems Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 282,493 $0.001000 $19.17 $19.17 1x $19.17 3.46%
Series A 374,274 $0.001000 $18.2 $18.2 1x $18.2 4.58%
To view Adarza BioSystems’s complete cap table history, request access »

Adarza BioSystems Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a biological assay platform designed to measure clinical and point-of-care samples. The company's platform
Biotechnology
Saint Louis, MO
13 As of 2022

Ithaca, NY
 

Toronto, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adarza BioSystems Competitors (6)

One of Adarza BioSystems’s 6 competitors is Rheonix, a Venture Capital-Backed company based in Ithaca, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rheonix Venture Capital-Backed Ithaca, NY
ChipCare Formerly VC-backed Toronto, Canada
Dynamic Biosensors Formerly VC-backed Munich, Germany
Abaxis Formerly VC-backed Union City, CA
Correlia Biosystems Venture Capital-Backed Berkeley, CA
To view Adarza BioSystems’s complete competitors history, request access »

Adarza BioSystems Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • 3

    Granted

  • Pending

  • Expiring in next 12 mo

Adarza BioSystems Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022025967-A1 Ultra sensitive methods Inactive 28-Jul-2020
WO-2021183798-A1 Consumable system for molecule detection assays Inactive 11-Mar-2020
ES-2857574-T3 Competitive small molecule detection assays using array imaging reflectometry Active 23-Jul-2015
EP-3325946-A1 Competitive small molecule detection assays using arrayed imaging reflectometry Active 23-Jul-2015
EP-3325946-A4 Competitive small molecule detection assays using arrayed imaging reflectometry Active 23-Jul-2015 G01N33/54373
To view Adarza BioSystems’s complete patent history, request access »

Adarza BioSystems Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Adarza BioSystems FAQs

  • When was Adarza BioSystems founded?

    Adarza BioSystems was founded in 2008.

  • Where is Adarza BioSystems headquartered?

    Adarza BioSystems is headquartered in Saint Louis, MO.

  • What is the size of Adarza BioSystems?

    Adarza BioSystems has 13 total employees.

  • What industry is Adarza BioSystems in?

    Adarza BioSystems’s primary industry is Biotechnology.

  • Is Adarza BioSystems a private or public company?

    Adarza BioSystems is a Private company.

  • What is Adarza BioSystems’s current revenue?

    The current revenue for Adarza BioSystems is .

  • How much funding has Adarza BioSystems raised over time?

    Adarza BioSystems has raised $53.9M.

  • Who are Adarza BioSystems’s competitors?

    Rheonix, ChipCare, Dynamic Biosensors, Abaxis, and Correlia Biosystems are some of the 6 competitors of Adarza BioSystems.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process